Cetuximab MMAE
Cetuximab MMAE is an antibody-drug conjugate (ADC) consisting of the EGFR-targeting humanized monoclonal antibody Cetuximab (HY-P9905) conjugated to VcMMAE (HY-15575) . Cetuximab MMAE exhibits antitumor activity[1].
Product Specifications
UNSPSC
12352203
Target
Antibody-Drug Conjugates (ADCs) ; EGFR; Microtubule/Tubulin
Related Pathways
Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
99.53
Smiles
[CetuximabMMAE]
Molecular Weight
150804 (average)
References & Citations
[1]Kyoji Tsuchikama, et al. Exploring the next generation of antibody–drug conjugates. Review Nat Rev Clin Oncol. 2024 Mar;21 (3) :203-223.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Scientific Category
ADC Related
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal FFAR2/GPR43 Antibody (1000624) [FITC]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
